Skip to main content

Day: March 6, 2024

Vishay Intertechnology Acquires Nexperia’s Newport Wafer Fab for $177 Million

Acquisition Accelerates Vishay’s SiC Production Plans MALVERN, Pa., March 06, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today announced that it has completed the acquisition of Nexperia’s wafer fabrication facility and operations located in Newport, South Wales, U.K. for approximately $177 million in cash, net of cash acquired. The Newport wafer fab, located on 28 acres, is an automotive-certified, 200mm semiconductor wafer fab with capacity to produce more than 30,000 wafers per month. The fab is the UK’s largest semiconductor fab with a long history in supplying components to the automotive and industrial markets. Vishay plans to position the facility as a manufacturing excellence center focusing on Net Zero Transformation of decarbonization and electrification. As a new member of the Compound Semiconductor...

Continue reading

Wolters Kluwer releases 2023 Annual Report

PRESS RELEASE Wolters Kluwer releases 2023 Annual Report Alphen aan den Rijn – March 6, 2024 – Wolters Kluwer, a global leader of professional information, software solutions, and services, today published its 2023 Annual Report, available on the Wolters Kluwer website. The Annual Report provides detailed insights into Wolters Kluwer’s financial and non-financial performance during 2023, including the company’s Environmental, Social and Governance (ESG) achievements. Nancy McKinstry, CEO and Chair of the Executive Board, commented: “The passion and commitment of our global team allowed us to deliver on our goals. Achievements included the creation of our new Corporate Performance & ESG division, plans to advance our own sustainability performance, and investments in advanced technology, such as Artificial Intelligence. We are focused...

Continue reading

Fourth quarter 2023 results – EUR 162 million net income in Q4 2023, contributing to a record full year 2023 net income of EUR 812 million Proposed regular dividend of EUR 1.8 per share

Press release6 March 2024 – N° 03 Fourth quarter 2023 results                 EUR 162 million net income in Q4 2023, contributing to a record full year 2023 net income of EUR 812 million Proposed regular dividend of EUR 1.8 per shareGroup net income of EUR 162 million in Q4 2023 (EUR 179 million excluding the mark to market impact of the option on own shares). For the full year 2023, the net income stands at EUR 812 million (EUR 780 million adjusted1) Group Economic Value2 under IFRS 17 of EUR 9.2 billion as of 31 December 2023, up +3.0%3 (+8.6% at constant economics3,4) compared with 31 December 2022, implying an Economic Value per share of EUR 51 (vs. EUR 50 as of 31 December 2022) Estimated Group solvency ratio of 209%5 as of 31 December 2023 Proposed regular dividend of EUR 1.8 per share for 2023 Annualized Return on Equity...

Continue reading

BridgeBio Pharma Announces Pricing of Public Offering of Common Stock

PALO ALTO, Calif., March 05, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced the pricing on March 5, 2024 of an underwritten public offering of 8,620,690 shares of its common stock at a public offering price of $29.00 per share, before deducting underwriting discounts and commissions. In addition, BridgeBio has granted the underwriters a 30-day option to purchase up to an additional 1,293,103 shares of its common stock on the same terms and conditions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $250.0 million, excluding any exercise of the underwriters’ option to purchase additional shares....

Continue reading

Viper Energy Announces Pricing of Secondary Common Stock Offering by Diamondback Energy, Inc.

MIDLAND, Texas, March 05, 2024 (GLOBE NEWSWIRE) — Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”) announced today the pricing of an underwritten public offering of 11,500,000 shares of its Class A common stock (the “Secondary Offering”) by Viper’s parent, Diamondback Energy, Inc. (the “Secondary Stockholder”). The gross proceeds from the sale of the shares by the Selling Stockholder will be approximately $402.5 million. Viper will not receive any proceeds from the sale of the shares by the Selling Stockholder. The Secondary Offering is expected to close on March 8, 2024, subject to customary closing conditions. The Selling Stockholder has also granted the underwriters a 30-day option to purchase up to an additional 1,725,000 shares of Viper’s Class A common stock. J.P. Morgan, Barclays, Evercore ISI and Goldman Sachs & Co. LLC...

Continue reading

Tims China to Present at Upcoming Conferences

SHANGHAI, China, and NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) — TH International Limited (NASDAQ THCH), the exclusive operator of Tim Hortons coffee shops and Popeyes restaurants in China (“Tims China” or the “Company”) will be attending and participating in the following upcoming conferences next week: Wednesday March 13: BofA Securities Consumer and Retail Conference 2024. Tims will participate in a fireside chat at 10.30am ET. Thursday March 14: UBS Global Consumer and Retail Conference 2024. Tims will participate in a fireside chat at 3pm ET. More information about Tims China’s presentations may be accessed by visiting https://ir.timschina.com from March 13. About TH International Limited TH International Limited (Nasdaq: THCH) (“Tims China”) is the parent company of the exclusive master franchisees of Tim Hortons coffee shops...

Continue reading

Akero Therapeutics Announces Pricing of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced today the pricing of an underwritten public offering of 11,000,000 shares of its common stock at a public offering price of $29.00 per share. All of the shares in the offering are being offered by Akero Therapeutics. In addition, Akero Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,650,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $319.0 million,...

Continue reading

DIRTT Announces Amendments to its Substantial Issuer Bid

CALGARY, Alberta, March 05, 2024 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”) (TSX: DRT; OTC: DRTTF), a leader in industrialized construction, announced today that it has effected certain amendments to the Company’s offer to purchase and accompanying issuer bid circular (the “Offer and Circular“) dated February 15, 2024, in connection with its previously announced substantial issuer bid and tender offer (the “Issuer Bid“). The amendments, the terms of which are set out in a notice of variation (the “Notice of Variation“) and Amendment No. 1 to the Company’s Tender Offer Statement on Schedule TO (the “Schedule TO-I/A“), each dated March 5, 2024, are solely to address comments from the Securities and Exchange Commission (the “SEC“)...

Continue reading

Melcor REIT announces Q4 and 2023 annual results

EDMONTON, Alberta, March 05, 2024 (GLOBE NEWSWIRE) — Melcor Real Estate Investment Trust (“Melcor REIT” or the “REIT”) (TSX: MR.UN) today announced results for the fourth quarter and year ended December 31, 2023. The annual Management Discussion & Analysis and Condensed Interim Financial Statements are available on our website (www.MelcorREIT.ca) under Financial Reports, or on SEDAR+ (www.sedarplus.ca). Andrew Melton, CEO of Melcor REIT commented: “In the face of persistent challenges, including escalating finance costs and the ongoing impact of inflation on operating and leasing expenses, we remain steadfast in our commitment to navigate these hurdles within our investment property portfolio. Our focus remains on tenant retention and actively leasing vacant space to offset the effects of rising...

Continue reading

CORRECTION – Sirios intersects 105.21 g/t Au over 1.0 m in the Eclipse area, Cheechoo property

Figure 1Inclined longitudinal section of the high-grade Eclipse gold zoneFigure 2Location of the Eclipse area in the Cheechoo gold depositMONTREAL, March 05, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Sirios Resources Inc. (TSX-V: SOI; OTCQB: SIREF) please note that all mentions of “105.21 g/t Au over 1.0 m” and “105.2 g/t Au / 1.0 m“, including in the headline, the first bullet point and on Figure 1, should now read “105.21 g/t Au over 0.8 m” and “105.2 g/t Au / 0.8 m” respectively. The corrected release follows: Sirios intersects 105.21 g/t Au over 0.8 m in the Eclipse area, Cheechoo property Sirios Resources Inc. (TSX-V: SOI; OTCQB: SIREF) is pleased to report partial results from the first two holes completed as part...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.